Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT02254824

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02254824
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02254824. Randomized; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
Condition
Hypertension
Intervention (Drug)
Xuezhikang
Intervention (Drug)
Atorvastatin
Intervention (Behavioral)
Lifestyle modification
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Peking Union Medical College Hospital (class: other)
Collaborator
Beijing Hospital of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct02254824
Content hash
b737424aa705169439151851073988bd18e72d0b8270b8daabdfa6b615655efc